These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8911103)

  • 21. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of endometrium during tamoxifen therapy of breast cancer].
    Obrebowska A; Sibila-Owczarska A; Sajdak S
    Ginekol Pol; 2002 Nov; 73(11):1109-12. PubMed ID: 12722407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 24. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
    Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F
    Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-grade endometrial stromal sarcoma following tamoxifen treatment.
    Engin H
    Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
    [No Abstract]   [Full Text] [Related]  

  • 26. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G; Hahn U; Schmidt D
    Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen and risk of endometrial cancer.
    Narod SA; Pal T; Graham T; Mitchell M; Fyles A
    Lancet; 2001 Jan; 357(9249):65-6; author reply 67. PubMed ID: 11197376
    [No Abstract]   [Full Text] [Related]  

  • 28. Tamoxifen and risk of endometrial cancer.
    Marsh F; Mayfield M
    Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197382
    [No Abstract]   [Full Text] [Related]  

  • 29. Tamoxifen and risk of endometrial cancer.
    Kairies P
    Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197381
    [No Abstract]   [Full Text] [Related]  

  • 30. Tamoxifen and risk of endometrial cancer.
    Dickson MJ; Pandiarajan T
    Lancet; 2001 Jan; 357(9249):67-8. PubMed ID: 11197380
    [No Abstract]   [Full Text] [Related]  

  • 31. Tamoxifen and risk of endometrial cancer.
    Lasset C; Bonadona V; Mignotte H; Brémond A
    Lancet; 2001 Jan; 357(9249):66-7. PubMed ID: 11197379
    [No Abstract]   [Full Text] [Related]  

  • 32. Tamoxifen and risk of endometrial cancer.
    Atkins CD
    Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197378
    [No Abstract]   [Full Text] [Related]  

  • 33. Tamoxifen and risk of endometrial cancer.
    Tempfer C; Kubista E
    Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197377
    [No Abstract]   [Full Text] [Related]  

  • 34. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
    Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions.
    Houghton JP; Ioffe OB; Silverberg SG; McGrady B; McCluggage WG
    Mod Pathol; 2003 Apr; 16(4):395-8. PubMed ID: 12692205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial].
    Noël G; Mezziou M; Mazeron JJ
    Cancer Radiother; 1999; 3(6):524-5. PubMed ID: 10630169
    [No Abstract]   [Full Text] [Related]  

  • 37. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
    Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
    Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    McCaul KA
    Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
    [No Abstract]   [Full Text] [Related]  

  • 40. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.